Zobrazeno 1 - 10
of 916
pro vyhledávání: '"Kallenberg, C."'
Publikováno v:
Epidemiology and Infection, 1995 Feb 01. 114(1), 133-141.
Externí odkaz:
https://www.jstor.org/stable/3864187
Publikováno v:
Epidemiology and Infection, 1994 Apr 01. 112(2), 367-373.
Externí odkaz:
https://www.jstor.org/stable/3864538
Autor:
Mavrogeni, S., Kitas, G. D., Lamb, H. J., Psychoyios, K., Dimitroulas, T., Koutsogeorgopoulou, L., Boki, K., Vartela, V., Kolovou, G., Markousis-Mavrogenis, G., Kallenberg, C. G., Guillevin, L., DIMITRIOS VASSILOPOULOS
Publikováno v:
Clinical and Experimental Rheumatology, 36(2), S152-S159
Scopus-Elsevier
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::12afc1940cd7a3088c98e7aa10b6d836
http://hdl.handle.net/1887/119422
http://hdl.handle.net/1887/119422
Autor:
Bossuyt, X, Cohen Tervaert, J, Arimura, Y, Blockmans, D, Flores Suárez, L, Guillevin, L, Hellmich, B, Jayne, D, Jennette, J, Kallenberg, C, Moiseev, S, Novikov, P, Radice, A, Savige, J, SINICO, RENATO ALBERTO, Specks, U, van Paassen, P, Zhao, M, Rasmussen, N, Damoiseaux, J, Csernok, E.
Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). According to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::66c2bcc7de5994ab86397680963ae7ca
http://hdl.handle.net/10281/169882
http://hdl.handle.net/10281/169882
Autor:
Kallenberg, C. G. M.1 c.g.m.kallenberg@int.umcg.nl
Publikováno v:
Clinical & Experimental Immunology. Dec2007, Vol. 150 Issue 3, p437-441. 5p. 2 Charts, 2 Graphs.
Autor:
Kallenberg, C. G. M.1,2 c.g.m.kallenberg@int.umcg.nl, Stegeman, C. A.1,2, Bootsma, H.1,2, Bijl, M.1,2, Limburg, P. C.1,2
Publikováno v:
Lupus. 2006, Vol. 15 Issue 7, p397-402. 6p. 2 Charts.
Autor:
Misch, K. J., Kallenberg, C. G. M.
Publikováno v:
British Medical Journal (Clinical Research Edition), 1985 Jun . 290(6484), 1829-1829.
Externí odkaz:
https://www.jstor.org/stable/29519583
Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::287b435f00e1560fe5890bd4cd07d7fc
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003772
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003772
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raphaele, Seror, Xavier, Mariette, Simon, Bowman, Gabriel, Baron, Jacques Eric Gottenberg, Hendrika, Boostma, Elke, Theander, Athanasios, Tzioufas, Claudio, Vitali, Philippe, Ravaud, Asmussen European League Against Rheumatism Sjögren'S Task Force, (., Jacobsen, S., Bijlsma, J. W., Kruize, A. A., Bombardieri, S., Bookman, A., Bootsma, H., Kallenberg, C., Bowman, S. J., Brun, J. G., Jonsson, R., Carsons, S., De Vita, S., Del Papa, N., Devauchelle, V., Saraux, A., Dorner, T., Gerli, R., Gottenberg, J. E., Sibilia, J., Hachulla, E., Illei, G., Isenberg, D., Jones, A., Manoussakis, M., Tzioufas, A., Mariette, X., Montecucco, C., Omdal, R., Parke, A., Praprotnik, S., Tomsic, M., Price, E., Ramos Casals, M., Ravaud, P., Seror, R., Smolen, J., Steinfeld, S., Sutcliffe, N., Theander, E., Jacobsson, L., Valesini, Guido, Vitali, C., Vivino, F. B.
Publikováno v:
ARTHRITIS CARE & RESEARCH, 62(4), 551-558. Wiley
Objective. To assess and compare the sensitivity to change of the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index (ESSDAI) with that of other primary Sjogren's syndrome (SS) disease activity indexes.Methods. We abstracted